Evidence map›Paper›PMID 36035011›Full record

ArticleAnnals of translational medicine2022

Characterization of extrachromosomal circular DNA in patients with acute myeloid leukemia: proof-of-concept report using cohorts from Beijing and Shanghai.

Liren Qian, Xinxin Xia, Jiaxin Liu, Xiaoping Chen, Yu Liu, Xiaona Wang, Sabina Iluta, Sergiu Pasca, Diana Gulei, Ciprian Tomuleasa

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. The important role of the eccDNA in tumors.Annals of translational medicine · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Liren Qian *Department of Hematology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
Xinxin Xia *Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiaxin LiuDepartment of Hematology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Xiaoping ChenDepartment of Hematology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Yu LiuDepartment of Hematology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Xiaona WangDepartment of Hematology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Sabina IlutaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Sergiu PascaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Diana GuleiMedfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Ciprian TomuleasaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36035011
PMCPMC9403928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.